Navigation Links
New FDA Approved Drug NATRECOR For Heart Failure Patients

The US government has approved a genetically engineered drug called NATRECOR to ease the breathing of hospitalized congestive heart failure patients.

Congestive heart failure is a condition // in which the heart can't pump enough blood to meet the needs of the body's other organs. Most of the patients with congestive heart failure suffer flare-ups in which they gasp for breath and need hospitalization.

The U.S. Food and Drug Administration approved an injection of Natrecor as a way to treat these acute flare-ups. Natrecor, known chemically as nesiritide, is a biologically engineered version of a natural hormone that helps dilate blood vessels. That dilation helps blood flow from the weakened heart. But it also can cause seriously low blood pressure.

Two years ago, the FDA rejected approval of Natrecor because it caused so many cases of hypotension rates of 8 percent to 14 percent, depending on the dose used. Hence studies were conducted in another study group of 498 patients with a much smaller dose. This time, low blood pressure struck only about 4 percent of patients. So the FDA approved an injection containing the lower Natrecor dose.

Studies showed patients could breathe better as blood circulation and lung congestion improved with Natrecor treatment. California-based Scios Pharmaceuticals said it will start shipping Natrecor to hospitals this week and each vial, a day's treatment, will cost $380.


'"/>




Page: 1

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New Oral Rinse For Gingivitis Approved By FDA
4. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
5. AIDS Generic Drugs Approved by FDA for Sale in US
6. FDA Approved Nerve-Stimulation Therapy Now Available In New York
7. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
8. Pfizer’s Eraxis Approved By The FD
9. Inhalers for Kids Was Approved By the FDA
10. Alcoholism Drug Vivitrol Approved By FDA
11. Drug Approved to Curb Alcohol Dependency
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 14, 2018 , ... REMS: Requirements, Regulation, and Enforcement:, ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/remsrre ... enforcement tool. A constantly evolving enforcement tool. , In September the FDA added ...
(Date:11/13/2018)... ... 2018 , ... A survey by the publishers of ADC Review | ... therapies reached U.S. $ 4 billion. Approximately forty-five percent of this market included Antibody-drug ... (including ADCs) is expected to grow significantly, to U.S. $ 17 billion by 2023. ...
(Date:11/13/2018)... ... November 13, 2018 , ... The Centers for Medicare ... Rule and identified seven high volume current procedural terminology (CPT) codes as potentially ... CMS requested the RUC (Relative Value Update Committee) of the American Medical Association ...
(Date:11/13/2018)... ... 13, 2018 , ... As California deals with the most ... to help policyholders through the recovery process. , “The insurance industry’s overwhelming ... president of state affairs, western region. “We urge policyholders to heed the warnings ...
(Date:11/13/2018)... , ... November 13, 2018 , ... ... List to Serve Children with Autism Spectrum Disorder. , Trumpet Behavioral Health (“Trumpet”) ... offering high-quality ABA therapy services include: , Austin, TX; Cincinnati, OH; Columbus, OH; ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... American Bancard, ... in the U.S. and Canadian markets. TouchSuite will underwrite merchants selling CBD ... thorough review and understanding of the risks associated with the industry. CBD accounts ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... ... Society of America (CMSA) Conference & Expo, the only case management conference enriching ... The Mirage in world famous Las Vegas, NV. Industry professionals will convene to ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... ... world data, today announced that the company has been awarded a $225,000 Phase ... of the National Institutes of Health (NIH). , The pursuit of useful, well-structured ...
Breaking Medicine Technology: